Predictive Markers of Response to the MDM2 Degrader KT-253
October 24, 2024
Predictive Markers of Response to the MDM2 Degrader KT-253
EORTC-NCI-AACR Symposium 2024
Nancy Dumont, Rahul Karnik, Yogesh Chutake, Joyoti Dey, Susanne Breitkopf, Charles Lincoln Howarth, Carol Meeske, Alyssa Fasciano, Samson Ghilu, Peter Houghton, Rebecca Mosher, Jared Gollob, and Juliet Williams
Area of Focus
Oncology
Programs
MDM2 (KT-253)
Indications
Liquid Tumors
Solid Tumors
Development Stage
Pre-clinical Data
Share
